Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2022.May.06

The Company's Board of Directors resolved to convene the 2022 Annual General Shareholders' Meeting (Change of location and new approval)

2022.May.06

Announcement of the Consolidated Financial Statements for the first quarter of 2022 were approved by the Board of Directors

2022.May.03

Announcement on behalf of Amaran that the BOD resolved to revise the Regulations for Issuance and Subscription of 2020 Employee Stock Options

2022.May.03

Announcement on behalf of Amaran of not Distributing Dividends of 2021

2022.May.03

Announcement on behalf of Amaran that the BOD resolved to convene the 2022 Annual General Shareholders' Meeting

2022.May.03

OBI-999 ”Conjugated Biological Molecules, Pharmaceutical Compositions and Methods“ Was Granted By Taiwan Intellectual Property Office

2022.Apr.18

Announcement of the expiration of the Company's 2022 cash capital increase call period and the issuance of stocks

2022.Apr.06

AEMPS of Spain revokes previous approval for the Active Cancer Immunotherapy, OBI-822, to proceed to Phase III Clinical Trial

2022.Mar.25

Announcement of the Company's full receipt of cash capital increase in 2022 and the reference date of capital increase

2022.Mar.18

Announcement of not Distributing Dividends in 2021

News

Latest news

Events

Latest events